Maryland on Friday asked the U.S. Supreme Court to take a
case about whether it can enforce a 2017 state law that allows
its attorney general to sue generic drugmakers who sharply raise
prices on medications without running afoul of the U.S.
Allergan PLC is seeking to force two related companies that
sell compounded medications that compete with its Aczone acne
treatment to disclose their communications with law firm Ropes &
Gray, which wrote a memo supporting their business model's
A former employee of two Alabama doctors convicted of
operating a pill mill may not intervene in their criminal case
to claim a cut of funds they forfeited as a reward for pursuing
a related whistleblower case, a federal appeals court has ruled.
A federal jury has awarded the family of a deceased West
Virginia woman $1.25 million after finding that Boehringer
Ingelheim misrepresented the risks of its blood thinner Pradaxa,
causing her to suffer gastrointestinal bleeding.
A federal judge in Philadelphia has taken the unusual step
of ordering the unsealing of a whistleblower lawsuit accusing a
compounding pharmacy of defrauding government healthcare
programs despite requests by the U.S. Justice Department to keep
the case sealed.
A federal judge has rejected motions by 20 drug companies
including Mylan NV and Teva Pharmaceutical Industries Ltd to
dismiss lawsuits accusing them of conspiring to raise the prices
for six generic drugs including the common antibiotic
A federal judge has nearly doubled how much must be held
back from any settlements with testosterone replacement drug
manufacturers to potentially compensate plaintiffs lawyers for
working on matters related to the mass tort litigation.
A federal appeals court has overturned the certification of
a class of purchasers of Asacol, an ulcerative colitis drug, who
accused drug manufacturer Warner Chilcott, now owned by Allergan
PLC, of suppressing generic competition for the medication.
Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively raising prices for insulin.
BOSTON A former State Street Corp executive was sentenced on Tuesday to 18 months in prison after being convicted of taking part in a scheme to overcharge customers of the bank by applying secret commissions on billions of dollars' worth of trades.